Q4 2025 Earnings Call February 12, 2026 2:00 AM ESTCompany ParticipantsBernt Omdal - Chief Executive OfficerVidar Jerstad - ...
Three developers with a mix of local and national experience are vying to rebuild the Riviera Beach waterfront with proposals ranging from the moderate to the sublime.
Beyond VK2735, Viking is advancing an amylin receptor agonist as a complementary obesity mechanism, aiming to deepen its metabolic franchise. An investigational filing is expected this quarter, with ...
Some ’80s sports cars aged badly. Others became classics. These are the ones people still want, decades later, and for good ...
Viking Therapeutics, Inc. (Viking) , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its financial ...
Viking Therapeutics posts a wider-than-expected Q4 loss, but shares jump as it advances oral VK2735 into late-stage obesity ...
When Wyoming's legendary 1-million-acre Pathfinder Ranches was purchased in January, speculation was rife about the ...
Make time for BEST Valentines Gift's In Brooklyn on the Brooklyn Patch calendar ...
Dutch ovens, juicers, coffee gear, and more — these Prime-only kitchen deals are going fast.